Mednet Logo
HomeHospital Medicine
Hospital Medicine

Hospital Medicine

Physician discussions on inpatient care, transitions of care, diagnostic reasoning, and hospital-based protocols.

Recent Discussions

Do you use combination therapy for persistent MSSA bacteremia?

2
4 Answers

Mednet Member
Mednet Member
Infectious Disease · Southern California Infectious Diseases Associates

I don’t think I’ve ever come across a situation where the problem wasn’t source control…

How do you decide which IV opioid to use for symptom relief at the end of life?

2
1 Answers

Mednet Member
Mednet Member
Hospital Medicine · University of Washington

For patients at the end of life who need IV medications for symptom relief, I choose morphine, hydromorphone, or fentanyl depending on the patient's baseline opioid tolerance, symptom burden, and their kidney and liver function. Morphine is the lowest potency of these three options and is a good cho...

What are some practical steps physicians can take to optimize mobility and reduce falls in hospitalized patients?

1 Answers

Mednet Member
Mednet Member
Hospital Medicine · Yale School of Medicine/Yale-New Haven Hospital

Falls have long been a complex challenge for clinicians, inpatient unit leaders, and hospitals/health systems in the management of hospitalized patients. The solution is nuanced and depends on many patient- and facility-related factors – no single intervention is enough on its own. Evidence from rec...

Should patients starting cyclophosphamide be screened routinely for latent tuberculosis (TB)?

2
2 Answers

Mednet Member
Mednet Member
Rheumatology · Virginia Commonwealth University

Yes, I think patients starting Cyclophosphamide should be screened routinely for latent TB since CYC is a strong immunosuppressant and increases the risk of TB reactivation. The issue is that CYC is often being considered for life or organ-threatening situations, for which it may not be ideal to wai...

Do you routinely monitor urine toxicology for primary care patients prescribed tramadol for chronic pain?

2 Answers

Mednet Member
Mednet Member
Primary Care · Boston University School of Medicine

I get a urine at least once per year for someone on a daily opioid agonist for a chronic pain syndrome. Tramadol carries the same risks as other opioid analgesics. For anyone on chronic opioid therapy, I also complete a controlled substance agreement, which I try to approach like an informed consent...

What are your preferred non-benzodiazepine therapies for the hyperactive/agitated phase of methamphetamine withdrawal, both in the hospital and in the office?

3
2 Answers

Mednet Member
Mednet Member
Psychiatry · SaVida Health

In our outpatient substance use disorder practice, we tend to use lisdexamphetamine (Vyvanse) at fairly high doses off-label for patients with meth withdrawal. We establish a buddy system preferably with someone who lives with them, provide Suicide hotline phone number, describe reasons to transport...

What are your preferred non-benzodiazepine therapies for the hyperactive/agitated phase of methamphetamine withdrawal, both in the hospital and in the office?

3
2 Answers

Mednet Member
Mednet Member
Psychiatry · SaVida Health

In our outpatient substance use disorder practice, we tend to use lisdexamphetamine (Vyvanse) at fairly high doses off-label for patients with meth withdrawal. We establish a buddy system preferably with someone who lives with them, provide Suicide hotline phone number, describe reasons to transport...

Do you routinely treat patients with neurosyphilis with IM penicillin for 1-3 weeks after completing a full treatment course of IV penicillin?

1
3 Answers

Mednet Member
Mednet Member
Infectious Disease · University of Washington Center for AIDS and STD

The same question was asked almost exactly two years ago. Repeating the same reply with minor edits: This has been a topic of a debate among syphilis experts for decades. There are no data at all on whether there is benefit (e.g. in preventing later relapse) in adding low-dose but long-acting penici...

What studies do you find helpful to determine if an axial spondyloarthritis patient presenting late in the disease course with significant irreversible joint damage may benefit from immunosuppression?

3
1 Answers

Mednet Member
Mednet Member
Rheumatology · Vanderbilt University Medical Center

I think this is a very clinically relevant question. While I do not know of any study that specifically examines this question, studies suggest that tumor necrosis factor inhibitors may inhibit long-term radiographic progression and improve functional status. Long-term extension of secukinumab trial...

How do you approach the concept of spondyloarthritis disease activity "burning out" and no longer requiring immunosuppression?

2
1 Answers

Mednet Member
Mednet Member
Rheumatology · Mobile Medical Care Inc

This is a difficult question to discuss academically, as we will have to accept a definition for “burning out,” which may or may not be synonymous with remission or a state that will support drug-free remission. That being stated, the possibility of spondyloarthritis going into remission (no “inflam...